Thomas J. Schall - Feb 22, 2022 Form 4 Insider Report for ChemoCentryx, Inc. (CCXI)

Role
President and CEO, Director
Signature
/s/ Susan M. Kanaya, as Attorney-in-Fact
Stock symbol
CCXI
Transactions as of
Feb 22, 2022
Transactions value $
$0
Form type
4
Date filed
2/25/2022, 07:39 PM
Previous filing
Jan 4, 2022
Next filing
Aug 8, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CCXI Restricted Stock Units Award +153K 153K Feb 22, 2022 Common Stock 153K Direct F1, F2
transaction CCXI Stock Option (right to buy) Award +193K 193K Feb 22, 2022 Common Stock 193K $29.83 Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of CCXI common stock.
F2 The restricted stock units awarded on February 22, 2022, vests in four equal installments on January 1, 2023, January 1, 2024, January 1, 2025, and January 1, 2026, subject to the Reporting Person's continued service to the Company on such date. Shares will be delivered to the Reporting Person within thirty (30) days following vest date.
F3 The option was granted on February 22, 2022, and 25% of the total number of shares of common stock subject to the option vests on January 1, 2023, and 1/48th of the total number of shares of common stock subject to the option vests monthly thereafter, subject to the Reporting Person's continued service to the Company on each such vesting date.
F4 Not applicable.